Effect of Mucuna pruriens Seed Extract Pretreatment on the responses of spontaneously beating Rat Atria and Aortic Ring to Naja sputatrix (Javan Spitting Cobra) Venom by Fung, Shin Yee et al.
Hindawi Publishing Corporation
Evidence-Based Complementary and Alternative Medicine
Volume 2012, Article ID 486390, 6 pages
doi:10.1155/2012/486390
Research Article
Effect of Mucuna pruriens Seed Extract Pretreatment on
the Responses of Spontaneously Beating Rat Atria and Aortic
Ring to Naja sputatrix (Javan Spitting Cobra) Venom
Shin Yee Fung,1 Nget Hong Tan,1 Si Mui Sim,2 and John C. Aguiyi3
1 Department of Molecular Medicine, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia
2 Department of Pharmacology, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia
3 Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmaceutical Sciences, University of Jos, P.M.B. 2084, Jos, Nigeria
Correspondence should be addressed to Shin Yee Fung, fungshinyee@gmail.com
Received 11 February 2011; Revised 20 April 2011; Accepted 12 May 2011
Academic Editor: Alvin J. Beitz
Copyright © 2012 Shin Yee Fung et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Mucuna pruriens Linn. (velvet bean) has been used by native Nigerians as a prophylactic for snakebite. Rats pretreated with M.
pruriens seed extract (MPE) have been shown to protect against the lethal and cardiovascular depressant eﬀects of Naja sputatrix
(Javan spitting cobra) venoms, and the protective eﬀect involved immunological neutralization of the venom toxins. To investigate
further the mechanism of the protective eﬀect of MPE pretreatment against cobra venom toxicity, the actions of Naja sputatrix
venom on spontaneously beating rat atria and aortic rings isolated from bothMPE pretreated and untreated rats were studied. Our
results showed that the MPE pretreatment conferred protection against cobra venom-induced depression of atrial contractility
and atrial rate in the isolated atrial preparations, but it had no eﬀect on the venom-induced contractile response of aortic ring
preparation. These observations suggested that the protective eﬀect of MPE pretreatment against cobra venom toxicity involves a
direct protective action of MPE on the heart function, in addition to the known immunological neutralization mechanism, and
that the protective eﬀect does not involve action on blood vessel contraction. The results also suggest that M. pruriens seed may
contain novel cardioprotective agent with potential therapeutic value.
1. Introduction
Mucuna pruriens Linn. (velvet bean) is found in Asia,
America, and Africa. It is a popular medicinal plant in
India [1] and contains protein (lectins, globulins, protease
inhibitors), fat and fatty acids, water, fiber, and L-DOPA
(or levodopa), among others. In certain regions of Nigeria,
the beans have been prescribed by traditional practitioners
as an oral prophylactic for snakebites [2]. The protective
eﬀect of the aqueous M. pruriens seed extract (MPE) has
been demonstrated in mice against Echis carinatus and cobra
venom [2, 3], and the protective eﬀect was shown to involve
an immunological neutralization mechanism. Indeed, pre-
liminary studies have shown that anti-M. pruriens seed
extract (anti-MPE) antibodies raised from rabbits were able
to neutralize the lethalities of several Asiatic cobra venoms
in mice [4]. Western blotting studies also showed that the
anti-MPE IgG cross-reacted with purified neurotoxin and
phospholipase A2 of Naja sputatrix (Javan spitting cobra)
venom [5]. Further in vivo studies showed that rats pre-
treated with MPE were protected against the cardiovascular
and respiratory depressant eﬀects of Calloselasma rhodos-
toma (Malayan pit viper) and N. sputatrix venoms [6, 7].
Histological studies showed that one of the main features
of the protective eﬀect of MPE pretreatment in rats against
the lethal eﬀect of cobra venom was prevention of venom-
induced histopathological changes in the heart [8]. This is of
particular interest as clinical and experimental observations
indicated that in cobra envenomation, cardiotoxicity may be
a more prominent feature than neurotoxicity [9, 10].
While the major protective mechanism of MPE pretreat-
ment appears to involve the neutralization of the venom
toxins by anti-MPE antibodies elicited by the MPE pretreat-
ment, the involvement of nonimmunological mechanism
cannot be ruled out. In this study, we investigated the eﬀect
of MPE pretreatment on the responses of isolated heart atria
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and aortic rings to N. sputatrix venom as part of our attempt
to understand the protective action of Mucuna pruriens seed
extract on the cardiovascular system.
2. Materials and Methods
2.1. Plant Material and Seed Extract. Mucuna pruriens Linn.
(family: Fabaceae, subfamily: Papilionoideae, genus: Mucuna,
species: pruriens) seeds were collected from Rukuba area
in Jos, Nigeria, with the aid of a traditional healer. They
were authenticated by Professor S. W. H. Hussini of the
Department of Botany, University of Jos. Voucher specimen
Number A102 is deposited in the Pharmacy Herbarium of
the University of Jos. The M. pruriens seed extract (MPE)
was prepared according to Aguiyi et al. [2]. Briefly, dried
M. pruriens seed meal (50 g) was soaked in distilled water
(100mL) for 24 h at 4◦C with stirring. The extract was
centrifuged at 10,000 g for 20min, and the supernatant is
termed M. pruriens seed extract (MPE). The extract was
freeze-dried, and resuspended in normal saline prior to
injection. MPE consists of both proteins and nonprotein
components [3].
2.2. Venom, Drug Standards, and Chemicals. Lyophilized
N. sputatrix (Javan spitting cobra, formerly known as
Naja naja sputatrix) venom was purchased from Latoxan
(Rosans, France), an established supplier of reliable venoms.
The venom is a pooled sample from adult snakes and
is from Indonesia. Carbachol (carbamylcholine chloride)
and phenylephrine were purchased from Sigma Chemical
Company (USA). All chemicals and reagents used in this
study were of ACS grade. Stock solutions of all chemicals
were prepared using ultrapure water. Dilutions of venom and
drugs were made in normal saline.
2.3. Animals. Male Sprague Dawley rats (220–300 g) were
used. All animals were handled according to guiding prin-
ciples given by the Council for International Organization of
Medical Sciences (CIOMS) on animal experimentation [11].
Animals were supplied by the Laboratory Animal Center of
the Faculty ofMedicine, University ofMalaya, and the animal
experimental protocol was approved by the Animal Care and
Use Committee of the Faculty.
2.4. Determination of Median Lethal Dose (LD50). The
intravenous median lethal dose (LD50 (i.v.)) was determined
by injection of various amounts of the venom into the caudal
veins of rats (n = 5), and the lethal eﬀect of the venom
was observed for 24 h. The LD50 (i.v.) was then calculated
according to the Spearman-Karber method [12].
2.5. Pretreatment of Rats. Rats were divided into two groups
(n = 9 for each group). Pretreatment of rats was conducted
according to the procedures of Guerranti et al. [3]. The
treated group consisted of rats injected withMPE at a dose of
21mg/kg (i.p.) at days 0, 7, and 14. The control (or untreated
group) was given a similar volume of saline. After 21 days, the
animals were killed, and isolated atria and aortic rings were
prepared.
2.6. Preparation of Spontaneously Beating Rat Atria. Rats
(pretreated and untreated) were stunned by a blow on the
head and exsanguinated by cutting the carotid arteries. The
paired rat atria were dissected out, cleaned of fatty tissues,
and suspended in a 10-mL organ bath containing Krebs-
Henseleit solution, maintained at 37◦C, and aerated with
95% O2 and 5% CO2. The composition of Krebs-Henseleit
solution was (mM): NaCl (118.4); NaHCO3 (25.0); MgSO4
(1.2); KCl (4.7); KH2PO4 (1.2); CaCl2 (2.5); glucose (11.1).
Under resting tension of 1.0 g, the spontaneously beating
atrial preparation was allowed to stabilize for at least 30min,
with change of the physiological salt solution every 15min.
Tension changes in the tissue were monitored via a force-
displacement transducer (model FT03C) that was connected
to MacLab data acquisition system (Version 3.5, Australia),
and the rate of atrial beats were estimated from the recording.
2.7. The Action of N. sputatrix Venom on Isolated Sponta-
neously Beating Rat Atria from MPE-Pretreated and Untreated
Rats. In two separate but parallel experiments, N. sputatrix
venom was added at a concentration of 5, 50, and 250 µg/mL
cumulatively at 15min interval to the tissues taken from
untreated (as controls) and MPE-pretreated animals. The
eﬀects of the venom on the atrial contractility and rate were
monitored at 5, 10, and 15min for each concentration. At the
end of the last 15min, after exposure to 250 µg venom/mL,
the preparation was washed with physiological salt solution,
and the atrial function was monitored for a further 15min.
2.8. Preparation of Rat Aortic Rings. The thoracic aorta was
gently excised, cleaned of surrounding fat and connective
tissues, and then cut into 4mm wide rings. Each aortic ring
was then suspended in an organ bath between two parallel
stainless steel hooks. One hook was fixed while the other
was connected to a force-displacement transducer (model
FT03C). The organ bath contained 10mL of Krebs-Henseleit
solution maintained at 37◦C and aerated with 95% O2 and
5% CO2 throughout the experiment. The responses of the
aortic ring were relayed to a MacLab data acquisition system
(Version 3.5, Australia). A resting tension of 2 g was applied
on the ring which was then allowed to equilibrate for 30min
before experimentation, with change of the physiological salt
solution every 15min. After equilibration, stimulation of the
rings with 60mM KCl was repeated until a stable contractile
response was achieved.
2.9. Eﬀect of N. sputatrix Venom on Aortic Rings of MPE-
Pretreated and Untreated Rats. Endothelium intactness of
aortic rings was checked by adding 2 µM carbachol (car-
bamylcholine, CCh) to the preparation precontracted with
1 µM phenylephrine (PE). Any preparation with <60% CCh-
induced relaxation on a PE-precontracted aortic ring was
discarded. Ten minutes after addition of carbachol, the
aortic ring was washed at least three times with fresh
Krebs-Henseleit solution and allowed to rest for 15min.
It was then exposed to N. sputatrix venom at 5, 50, and
250 µg/mL, added cumulatively at 15min interval, to observe
the eﬀects of the venom on the aortic rings prepared from
untreated and MPE-pretreated animals. At the end of the
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Figure 1: Eﬀect of Naja sputatrix venom on the atrial rate (TOP, venom concentration (a) = 5 µg/mL, (b) = 50 µg/mL, and (c) = 250 µg/mL)
and atrial contractility (BOTTOM, venom concentration (d) = 5 µg/mL, (e) = 50 µg/mL, and (f) = 250 µg/mL) of isolated atria from
untreated (dotted line) and MPE-pretreated rats (solid line). The isolated atrial preparations were suspended in a 10mL organ bath
containing Krebs-Henseleit solution maintained at 37◦C and aerated with 95% O2 and 5% CO2. The eﬀect of the venom on the atrial
rate and contractility was monitored for 15min for each concentration. Values represent mean ± S.E.M. (n = 9). ∗P < 0.05, ∗∗P < 0.01,
∗∗∗P < 0.001 compared to the untreated animals at the corresponding time using unpaired Student’s t-test. One way repeated measures
ANOVA followed by Bonferroni/Dunnett T3 post-hoc test were used to determine the eﬀect of time on the atrial rate and contractility
responses for each venom concentration. The eﬀect of time was only significant at 250 µg/mL in the untreated group, P < 0.001.
experiment, the functional intactness of the endothelium
of the aortic ring preparation was retested by repeating the
eﬀect of carbachol (2 µM) on PE-induced contraction. Tissue
responsiveness was also retested with 60mM KCl.
2.10. Statistical Analysis. All biological data are presented
as mean ± S.E.M. of n experiments. The eﬀect of time
or concentration was analyzed statistically using one-way
repeatedmeasures ANOVA, followed by Bonferroni/Dunnett
T3 post-hoc test for multiple comparison (SPSS V14, SPSS
Inc., Chicago, Ill, USA). The diﬀerence in the means between
the untreated (control) and MPE-treated groups at any par-
ticular time or concentration was analyzed using Student’s t-
test. Statistical significance in the diﬀerence between means
was indicated when P < 0.05.
3. Results
3.1. Determination of Median Lethal Dose (LD50). The
intravenous LD50 for N. sputatrix venom was determined to
be 0.83 µg/g in rats. The doses 5, 50, and 250 µg/mL used in
this study are therefore equivalent to approximately 0.3, 3.3,
and 16.6 times of LD50, respectively, assuming that the total
volume of blood in each young adult rat is approximately
20mL.
3.2. Eﬀect of N. sputatrix Venom on the Spontaneously Beating
Atria Isolated from MPE-Pretreated and Untreated Rats. N.
sputatrix venom caused both time-dependent and venom
concentration-dependent changes on the atrial contractility
and rate (Figures 1(a)–1(c): results expressed as % baseline
g tension and % baseline beats per minute, resp.). The
reduction of atrial rate was minimal at both 5 and 50 µg/mL
and became marked only at 250 µg/mL (P < 0.001). At
this highest venom concentration tested, the atrial rate was
reduced by 25, 34, and 40% from baseline, for the three
incubation time points of 5, 10, and 15min, respectively.
These reductions in atrial rate were completely prevented
in the atria isolated from MPE-pretreated rats (Figure 1(c),
solid lines). At 5 µg/mL, the venom induced minimum
change in the atrial rate of untreated rats. There was no
diﬀerence between the atrial rates of the MPE-pretreated
and untreated groups at all three monitored time points
(Figure 1(a), P > 0.05). At 50 µg/mL, there was a decreasing
trend in the atrial rate response to the venom in the untreated
group whereas theMPE-pretreated group actually showed an
increasing trend in the atrial rate response to the same dose
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of venom (Figure 1(b)). The diﬀerence between the means of
the two groups was small but significant at each of the three
incubation time points (P < 0.05).
The eﬀect of the venom on the contractility of the
isolated atria was more marked than that on the heart rate
(Figures 1(d)–1(f)). At a concentration of 250 µg/mL, the
venom drastically reduced the contractility of the untreated
(control) rat atria by 70, 81, and 87% at 5, 10, and 15min
incubation time, respectively (P < 0.001). In contrast, the
same venom concentration did not significantly reduce the
contractility of the atria from MPE-pretreated rats although
there was a downward trend over the 15min incubation
period (Figure 1(f)). At the two lower concentrations
studied, the venom reduced progressively the contractility of
atria from the untreated group whereas the venom showed
a tendency to increase the contractility of atria from MPE-
pretreated rats by 13–83% above the baseline (Figures 1(d)
and 1(e)).
The depressed atrial contractility and rate of both
untreated and MPE-pretreated rats did not return to their
respective baseline values even after repeated washings of the
preparation.
3.3. Eﬀect of N. sputatrix Venom on Aortic Rings of MPE-
Pretreated and Untreated Rats. To assess the tissue viability
and functional integrity of the endothelium, carbachol (CCh,
2 µM) was added to the endothelium-intact aortic ring at
the peak of phenylephrine (PE)-induced contraction. A near
complete relaxation (80.9 ± 4.7%, n = 18) of the ring
indicated that the endothelium preparation was functionally
intact (Figure 2, representative tracing). In a preliminary
study, this venom (10 and 100 µg/mL) was found to produce
a similar dose-dependent contraction when given at resting
tension andwhen given to a PE-precontracted aortic ring. No
relaxation response was observed. Therefore, all subsequent
studies involved giving cobra venom at resting tension only.
In the present study, the venom induced a concentration-
dependent contractile response on the aortic ring from the
untreated rats (Figure 2 and Table 1). These contractile
responses induced by venom given at resting tension,
however, were not significantly altered byMPE-pretreatment
at all the three venom concentrations tested (P > 0.05,
Table 1).
4. Discussion
Earlier studies showed that the protective eﬀect of M.
pruriens seed extract (MPE) pretreatment against the lethal
activities of E. carinatus and N. sputatrix venoms involved
an immunological mechanism. The pretreatment elicited
formation of antibodies in the mice or rats that were
capable of neutralizing certain snake venom toxins [3, 4].
Fung et al. [6] reported that rats pretreated with the MPE
were protected against the cardiovascular depressant eﬀects
of N. sputatrix venoms, including depression in blood
pressure and heart rate. This present paper reports our
eﬀort to further investigate the protective mechanism(s) of
the MPE pretreatment. Specifically, we aim to answer two
questions: Firstly, is immunological neutralization of venom
Table 1: Eﬀects of Naja sputatrix venom on the contraction of
aortic rings isolated from MPE-pretreated and untreated rats.
Venom
concentration
(µg/mL)
Aortic ring contraction
(% phenylephrine contraction)
Untreated MPE-pretreated
5 3.5 ± 1.6 5.3 ± 2.0
50 16.5 ± 2.9## 14.6 ± 2.7#
250 112.5 ± 14.9### 115.7 ± 15.4###
Values represent mean ± S.E.M. (n = 9). The eﬀect of concentration
was analysed using one-way repeated measures ANOVA followed by
Benferroni/Dunnett T3 post-hoc test. #P < 0.05, ##P < 0.01, ###P <
0.001 compared to 5 µg/mL. The diﬀerence in the means between the
untreated and the MPE-pretreated groups was not significant at all three
venom concentrations. P > 0.05, unpaired Student’s t-test.
toxins the only mechanism by which MPE pretreatment
protect against cobra venom? Secondly, does the protective
action of MPE pretreatment against the venom-induced
cardiovascular eﬀect (in particular the hypotensive eﬀect)
involve the heart alone, or does it involve the blood vessels
as well? To answer these two questions, we investigated
the eﬀects of N. sputatrix venom on isolated spontaneously
beating atria and aortic rings, taken from MPE-pretreated
and untreated rats.
Our studies using isolated atrial preparations showed
that the MPE pretreatment conferred protection against
cobra venom-induced depression of heart rate and con-
tractility, at both 50 µg/mL (equivalent to 3.3 LD50) and
250 µg/mL (equivalent to 16.6 LD50). At 5 µg/mL (equivalent
to 0.3 LD50), the amount of venom used was too low to
cause any observable adverse eﬀects on atrial contractility
and rate from untreated rats. These results showed that
the protection against venom-induced hypotensive eﬀect
in the MPE-pretreated rats reported in the anesthetized
animal study [7] involves protection against venom-induced
harmful eﬀects to the heart. This protective action of
MPE-pretreatment, however, was not suﬃcient to prevent
venom-induced damages to the heart at very high venom
concentration, as repeated washings after the 250 µg/mL
treatment failed to restore the atrial contractility and rate to
the baseline, indicating that the venom has already caused
permanent damages to the heart. This is consistent with the
earlier report that lethal dose of N. sputatrix venom can lead
to histopathological changes in cardiac muscle [8].
In addition, the present results also support our hypoth-
esis that immunological neutralization is not the only mech-
anism involved in the protective eﬀect of MPE pretreatment
against cobra venom, as the experiments reported here were
in vitro experiments using isolated atrial preparations, and
there was no serum (and hence no anti-MPE antibodies)
present in the tissue bath. The mechanism of cobra venom-
induced cardiac toxicities is still not fully understood, even
though it certainly involves the venom cardiotoxin and
phospholipases A2 [13, 14]. It is important to note that
the present studies involved the action of N. sputatrix
venom on isolated atrial preparations isolated from animals
sacrificed 7 days after the last MPE treatment. The eﬀects
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Figure 2: Representative tracing showing the eﬀects of diﬀerent concentrations of Naja sputatrix venom (NSV) on the endothelium-intact
aortic ring isolated from untreated rat. Cumulative additions of the N. sputatrix crude venom, at final bath concentrations of 5, 50, and
250 µg/mL, induced a contractile eﬀect on the aortic ring preparation. Subsequent to testing the venom, the preparation was repeatedly
washed with fresh Krebs-Henseleit solution. Potassium chloride (KCl), phenylephrine-(PE-) and carbamylcholine chloride (CCh) were
given before and after the venom dose to check for the tissue viability and endothelium integrity.
of seed constituents such as L-DOPA (which can produce
dopamine with positive chronotropic and positive inotropic
eﬀects on the heart) and other small molecule, water-soluble
xenobiotic compounds on the animal are relatively short-
term and will not be expected to have an eﬀect 7 days after
administration.
It would appear that the MPE pretreatment has a direct
action on rat atria, which may induce gene expression
changes to enhance the heart’s resistance to the cardiotoxic
eﬀect of cobra venom toxins. Interestingly, the contractility
of the atrial preparations from MPE-pretreated rat increased
transiently on exposure to low doses of the cobra venom (5
and 50 µg/mL). The mechanism of this unexpected increase
in atrial contractility is unclear, but it is probably related
to some adaptive response of the atria (from the pretreated
rats) to venom exposure. The phenomenon supports the
suggestion that MPE pretreatment has a direct action on
rat heart, rendering it more resistant to venom-induced
cardiotoxicity.
The results from the in vitro aortic ring isolated from
untreated rats showed that N. sputatrix venom caused
contraction of the aortic ring in a concentration-dependent
manner, which may be due to interactions between venom
toxins and postsynaptic receptors in the blood vessel. Alter-
natively, the venom toxins could act directly on the muscu-
lature to depolarize the membrane, leading to an increase in
intracellular Ca2+ level and ultimately a contractile response.
Aortic rings isolated from MPE-pretreated rats demon-
strated the same concentration-dependent contraction
showing that MPE pretreatment does not protect against the
vasoactive action of cobra venom.
In conclusion, our results suggest that the protective
eﬀect of MPE pretreatment against cobra venom involves a
direct action of MPE on the heart, and, as such, immunolog-
ical neutralization is not the only mechanism of protective
eﬀect of the MPE pretreatment. Furthermore, the protective
action of MPE pretreatment against cobra venom-induced
cardiovascular depressant eﬀect is due to its action on
the heart and does not involve the blood vessel. Future
molecular and gene expression studies are being undertaken
to elucidate further the mechanism of the cardioprotective
action of the MPE pretreatment and to identify the MPE
constituent(s) responsible for the action, which could lead
to discovery of novel cardioprotective agent(s).
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